Using Modified Antigenic Sequences to Develop Cancer Vaccines: Are We Losing the Focus?
Are short synthetic peptides the key to developing cancer vaccines? And what are the obstacles in the way?
Tallennettuna:
| Julkaisussa: | PLoS Med |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
PLOS
2004
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC529422/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15578104/ https://ncbi.nlm.nih.govhttps://doi.org/10.1371/journal.pmed.0010026 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|